ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

IMNM Immunome Inc

16.00
0.25 (1.59%)
07 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Immunome Inc IMNM NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.25 1.59% 16.00 09:59:07
Open Price Low Price High Price Close Price Previous Close
15.75 15.12 16.1799 15.46 15.75
more quote information »

Recent News

Date Time Source Heading
02/5/202422:00BWImmunome Appoints Kinney Horn as Chief Business Officer
25/4/202422:26BWImmunome Appoints Sandra M. Swain to Board of Directors
05/4/202423:00BWImmunome to Present Preclinical Data for IM-3050, Its Lead..
29/3/202407:02BWImmunome Reports Full Year 2023 Financial Results and..
26/3/202423:00BWImmunome Completes Acquisition of AL102, a Phase 3 Asset for..
08/3/202400:00BWImmunome to Participate in the Leerink Partners Global..
02/3/202400:00BWImmunome to Participate in the TD Cowen 44th Annual..
22/2/202413:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202413:07EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/2/202400:15BWImmunome Recognizes Ayala Pharmaceuticals’ Announced..
17/2/202408:05BWImmunome Announces Closing of Public Offering and Full..
15/2/202408:11EDGAR2Form 8-K - Current report
15/2/202408:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/2/202414:38BWImmunome Announces Pricing of Public Offering of Common..
14/2/202408:36EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/2/202408:10EDGAR2Form 8-K - Current report
14/2/202408:05BWImmunome Announces Proposed Public Offering of Common Stock
13/2/202406:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202400:05EDGAR2Form 8-K - Current report
06/2/202400:00BWImmunome to Present at the Guggenheim Healthcare Talks 6th..
03/2/202408:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
01/2/202412:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202412:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202409:27EDGAR2Form 8-K - Current report
08/1/202423:05EDGAR2Form 8-K - Current report
08/1/202423:00BWImmunome Exclusively Licenses Zentalis ROR1 Antibody-Drug..
05/1/202409:40EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/1/202400:00BWImmunome Appoints Phil Roberts as Chief Technical Officer
04/1/202400:00BWImmunome to Present at the 42nd Annual J.P. Morgan..
03/1/202400:05EDGAR2Form 8-K - Current report
03/1/202400:00BWImmunome Appoints Carol A. Schafer to Board of Directors
30/12/202309:00EDGAR2Form 8-K - Current report
27/12/202300:35EDGAR2Form 8-K - Current report
27/12/202300:30GLOBEAtreca Announces Asset Purchase Agreement for Sale of..
16/12/202311:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202313:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202316:15EDGAR2Form EFFECT - Notice of Effectiveness
23/11/202308:02EDGAR2Form 8-K/A - Current report: [Amend]
17/11/202308:08EDGAR2Form S-3 - Registration statement under Securities Act of..
15/11/202322:03EDGAR2Form 8-K - Current report
11/11/202300:00BWImmunome to Present at the Stifel 2023 Healthcare Conference
10/11/202308:52EDGAR2Form 8-K - Current report
10/11/202300:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202300:00BWImmunome Reports Third Quarter 2023 Financial Results
09/11/202300:30EDGAR2Form 8-K - Current report
09/11/202300:00BWImmunome Appoints Jean-Jacques Bienaimé to Board of..
01/11/202309:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202309:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202309:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202323:00BWImmunome Appoints Bob Lechleider, M.D., as Chief Medical..

Your Recent History

Delayed Upgrade Clock